PolyPid Ltd (NAS:PYPD) Stock News, Headlines & Updates
PolyPid Ltd Stock News from GuruFocus
- 1
Jul 15, 2025
PolyPid Unveils a Long-Acting GLP-1 Receptor Agonists Delivery Platform Targeting the Diabetes and Weight Loss Market
Marketwired • 7:00am
Jun 18, 2025
PolyPid (PYPD) Receives Analyst Rating Update from Roth Capital | PYPD Stock News
GuruFocus News • 12:00pm
Roth Capital Adjusts PolyPid (PYPD) Price Target Amid New Financing | PYPD Stock News
GuruFocus News • 7:15am
Jun 17, 2025
PYPD: JMP Securities Lowers Price Target While Maintaining Market Outperform Rating | PYPD Stock News
GuruFocus News • 10:33am
PolyPid (PYPD) Price Target Adjusted Amid Financing Developments | PYPD Stock News
GuruFocus News • 10:16am
Citizens JMP Adjusts Price Target for PolyPid (PYPD) Amid Warrant Developments | PYPD Stock News
GuruFocus News • 4:46am
PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results
Marketwired • 7:00pm
Jun 16, 2025
PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results | PYPD Stock News
GuruFocus News • 6:45pm
Jun 09, 2025
PolyPid (PYPD) Rating Maintained as Price Target Raised by HC Wainwright | PYPD Stock News
GuruFocus News • 11:30am
PolyPid (PYPD) Target Price Increased as Phase 3 Trial Data Impresses | PYPD Stock News
GuruFocus News • 10:00am
PolyPid (PYPD) Reports Positive Phase 3 Trial Results for D-PLEX100 | PYPD Stock News
GuruFocus News • 7:01am
PolyPid Announces Positive Topline Results from Phase 3 SHIELD II Trial: D-PLEX??? Demonstrated Significant Reduction in Surgical Site Infections and Successfully Met Primary and All Key Secondary End
GuruFocus News • 6:47am
Jun 06, 2025
PolyPid to Host Conference Call and Webcast to Discuss D-PLEX??? SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025
Marketwired • 4:00pm
PolyPid to Host Conference Call and Webcast to Discuss D-PLEX??? SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025 | PYPD Stock News
GuruFocus News • 3:15pm
Jun 05, 2025
Roth Capital Initiates Coverage on PolyPid (PYPD) with a Buy Rating | PYPD Stock News
GuruFocus News • 1:30pm
PolyPid (PYPD) Stock Potential on D-PLEX100 Advances | PYPD Stock News
GuruFocus News • 6:01am
Jun 02, 2025
PolyPid (PYPD) Receives a 'Buy' Rating from HC Wainwright & Co. | PYPD Stock News
GuruFocus News • 6:00am
H.C. Wainwright Initiates Buy Coverage on PolyPid (PYPD) with $11 Target | PYPD Stock News
GuruFocus News • 5:47am
May 20, 2025
PolyPid to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
Marketwired • 6:00am
May 15, 2025
PolyPid Ltd (PYPD) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
GuruFocus News • 1:10am
Q1 2025 PolyPid Ltd Earnings Call Transcript
GuruFocus News • 11:10pm
May 14, 2025
PYPD Hosts Virtual Meeting Amidst Market Volatility | PYPD Stock News
GuruFocus News • 10:46am
PolyPid (PYPD) Prepares for Transformational 2025 with Promising SHIELD II Results | PYPD Stock News
GuruFocus News • 6:54am
PolyPid Provides Corporate Update and Reports First Quarter 2025 Financial Results
Marketwired • 6:00am
Apr 29, 2025
- 1
Show
Entries
Headlines
Total 0- 1
No recent news